Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Leader

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
International Journal of Molecular Sciences|January 8, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific MannerShirly Partouche, Idan Goldberg, Erez Halperin, et al.
Thrombosis and Haemostasis|January 1, 2019
Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based ExperimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2018
Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndromeRoy Ratzon, Shlomit Tamir, Tal Friehmann, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2018
Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot StudyAvi Leader, Noam Benyamini, Anat Gafter-Gvili, et al.
Blood Advances|August 22, 2025
Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolismSirui Ma, Yu-Cheng Chang, Cho Han Chiang, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot StudyAvi Leader, Anat Gafter-Gvili, Noam Benyamini, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitorsOded Icht, Naama Darzi, Shai Shimony, et al.
European Journal of Internal Medicine|March 17, 2020
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
British Journal of Haematology|June 15, 2024
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemiaAyala Gover-Proaktor, Dorit Leshem-Lev, Sabina Winograd-Katz, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
International Journal of Molecular Sciences|January 8, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific MannerShirly Partouche, Idan Goldberg, Erez Halperin, et al.
Thrombosis and Haemostasis|January 1, 2019
Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based ExperimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2018
Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndromeRoy Ratzon, Shlomit Tamir, Tal Friehmann, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2018
Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot StudyAvi Leader, Noam Benyamini, Anat Gafter-Gvili, et al.
Blood Advances|August 22, 2025
Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolismSirui Ma, Yu-Cheng Chang, Cho Han Chiang, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot StudyAvi Leader, Anat Gafter-Gvili, Noam Benyamini, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitorsOded Icht, Naama Darzi, Shai Shimony, et al.
European Journal of Internal Medicine|March 17, 2020
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
British Journal of Haematology|June 15, 2024
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemiaAyala Gover-Proaktor, Dorit Leshem-Lev, Sabina Winograd-Katz, et al.
Pageof 9